COORDINATION BOARD

a:7:{s:8:”location”;a:1:{i:0;a:1:{i:0;a:3:{s:5:”param”;s:4:”page”;s:8:”operator”;s:2:”==”;s:5:”value”;s:4:”1939″;}}}s:8:”position”;s:6:”normal”;s:5:”style”;s:7:”default”;s:15:”label_placement”;s:3:”top”;s:21:”instruction_placement”;s:5:”label”;s:14:”hide_on_screen”;s:0:””;s:11:”description”;s:0:””;}

/by

INFOS ESRs

a:7:{s:8:”location”;a:1:{i:0;a:1:{i:0;a:3:{s:5:”param”;s:9:”post_type”;s:8:”operator”;s:2:”==”;s:5:”value”;s:7:”student”;}}}s:8:”position”;s:15:”acf_after_title”;s:5:”style”;s:7:”default”;s:15:”label_placement”;s:3:”top”;s:21:”instruction_placement”;s:5:”label”;s:14:”hide_on_screen”;s:0:””;s:11:”description”;s:0:””;}

/by

Publications

a:7:{s:8:”location”;a:1:{i:0;a:1:{i:0;a:3:{s:5:”param”;s:9:”post_type”;s:8:”operator”;s:2:”==”;s:5:”value”;s:12:”publications”;}}}s:8:”position”;s:6:”normal”;s:5:”style”;s:7:”default”;s:15:”label_placement”;s:3:”top”;s:21:”instruction_placement”;s:5:”label”;s:14:”hide_on_screen”;s:0:””;s:11:”description”;s:0:””;}

/by

Kickoff meeting …checked! Enhpathy officially launched its program.

ENHPATHY is a multidisciplinary science consortium created in the frame of the Marie Sklodowska-Curie actions (MSCA)-ITN-ETN European Training Networks call and regrouping 12 academic and 3 non-academic European organisations in the continuum of basic, translational and clinical research on enhancers and associated diseases.

ESR applications to ENHPATHY ‘s training program : all applications should be made using the recruitment form to be published from March 15 to April 16, 2020 (https://www.enhpathy.eu/recruitment/).

Candidates with bioinformatics, genomics and/or molecular and cellular biology backgrounds are encouraged to apply.

/by

The (MSCA)-ITN the Innovative Training Networks program ENHPATHY to be launched on March 01, 2020

We are pleased to announce that the EnhPathy ITN H2020 PhD call will open on March 15th 2020. EnhPathy will be recruiting 15 PhD students to start their training program within the September-December 2020 period.

Please check the Nature careers ad on this link

ENHPATHY is a multidisciplinary science consortium created in the frame of the Marie Sklodowska-Curie actions (MSCA)-ITN-ETN European Training Networks call and regrouping 12 academic and 3 non-academic European organisations in the continuum of basic, translational and clinical research on enhancers and associated diseases.

All applications should be made using the recruitment form to be published from March 15 to April 16, 2020 (https://www.enhpathy.eu/recruitment/).

Candidates with bioinformatics, genomics and/or molecular and cellular biology backgrounds are encouraged to apply.

Read full press release

/by

Blocs Images

a:7:{s:8:”location”;a:1:{i:0;a:1:{i:0;a:3:{s:5:”param”;s:9:”post_type”;s:8:”operator”;s:2:”==”;s:5:”value”;s:4:”page”;}}}s:8:”position”;s:6:”normal”;s:5:”style”;s:7:”default”;s:15:”label_placement”;s:3:”top”;s:21:”instruction_placement”;s:5:”label”;s:14:”hide_on_screen”;s:0:””;s:11:”description”;s:0:””;}

/by

EMBO workshop, May 25-28 2020, Santander Spain (Rescheduled)

The new  EMBO workshop co-organized by Álvaro Rada-Iglesias, Salvatore Spicuglia and Susanne Mandrup is now open for registration –> https://bit.ly/2qoO4yC 

About the workshop : 
Mutations within coding genes have traditionally been considered the major genetic cause of human disease. However, it is becoming increasingly clear that the genetic, structural and/or epigenetic disruption of enhancers represent major etiological factors in numerous human diseases (i.e. enhanceropathies), ranging from rare congenital disorders to common diseases associated with ageing and lifestyle (e.g. cancer, diabetes). Although changes in enhancer activity are predicted to have broad pathological and therapeutic implications, we currently have a limited understanding of human enhanceropathies. This reflects, at least partly, our still primitive and partial understanding of the mechanisms whereby enhancers can control gene expression. To overcome these limitations, this workshop will bring together experts in enhancer biology, gene regulation and medical genetics that, during three days, will present their latest work. Our invited speakers and participants will discuss the multidisciplinary approaches required to investigate enhancer function as well as debate about the role of enhancers in fundamental biological processes (e.g. embryonic development, evolution) and in the etiology of human disorders. Ultimately, the goal of this EMBO Workshop will be to provide a complete view of how a deep and systems-level understanding of enhancer function can facilitate elucidating the molecular basis of human enhanceropathies.

/by

ENHPATHY 1ST MEETING – NOV 6TH 2018, MARSEILLE FRANCE

Brainstorming meeting gathering Enhpathy members – Marseille.

List of beneficiaries :

Salvatore Spicuglia (Coordinator), Institut Nationale pour la Santé et la Recherche Médicale (INSERM), France

Alvaro Rada-Iglesias (Vice Coordinator), University of Cantabria (UNICAN), Spain

Meritxell Alberich-Jorda, Institute of Molecular Genetics of the AS CR (IMG), Czech Republic

Robin Andersson, University of Copenhagen (UCPH), Denmark

Bart Deplancke, Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland

Jorge Ferrer, Centre for Genomic Regulation (CRG), Spain

Wouter de Laat, Royal Netherlands Academy of Arts and Sciences (KNAW), The Netherlands

Susanne Mandrup, University of Southern Denmark (SDU), Denmark

Gioacchino Natoli,  European Institute of Oncology (IEO), Italy

Dariusz Plewczynski, University of Warsaw (UoW), Poland

Pelin Sahlén, Royal Institute of Technology (KTH), Sweden

Judith Zaugg, European Molecular Biology Laboratory (EMBL), Germany

Joris van Arensbergen, Gen-X B.V. (Gen-X), The Netherlands

Julia Sepulveda Diaz, ELVESYS SAS (Elvesys), France

Mileidys Perez Alea, Advances BioDesign (ABD), France

List of partnering organisations :

Christian Thirion (Sirion), Germany

Gonzalo R. Ordóñez (Dreamgenics), Spain

Remi Terranova (Novartis Pharma AG), Switzerland

James B. Meigs, Alisa Manning (TOPMed), United States of America

Thomas Lemberger (GLWF, EMBO Press), Germany

J.C. Fitzsimons (Leadership Sculptor), Germany

Jean M. Grangeon (KOM Agency), France

Jacques van Helden (Institut Français de Bioinformatique)

Alain Arnaudet (La Friche Belle de Mai), France

Jorge Ferrer (UPF, Universitat Pompeu Fabra), Spain

Meritxel Alberich-Jorda (CUNI, Univerzita Karlova, Charles University), Czech Republic

Wouter de Laat (UU, Universiteit Utrecht), Netherlands

/by

QUESTION ABOUT ENHPATHY?

LET’S TALK!

Marie CurieThis project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 860002. The information contained in this website reflects only the authors’ view. REA and EC are not responsible for any use that may be made of this information.